Development of a multivariate model with desirability-based optimization for determination of atenolol and hydrochlorothiazide by eco-friendly HPLC method with fluorescence detection

© 2021 Wiley-VCH GmbH..

Determination of a widely used antihypertensive combination of atenolol and hydrochlorothiazide was achieved by rapid and eco-friendly high-performance liquid chromatography method combined with fluorescence detection. The response surface methodology is conducive to the complete separation of the two drugs in a shorter analysis time. The separation of the mixture was achieved using an Inertsil C18 analytical column (150 × 4.6 mm, 5 µ). The mobile phase used was ethanol: potassium dihydrogen phosphate at pH 3 (65:35 v/v) and the flow rate was 0.7 mL/min. The fluorescence detector operated at excitation and emission wavelengths of 230 and 310 nm (atenolol) and 270 and 375 nm (hydrochlorothiazide). The linearity of the developed method covered a concentration of atenolol of 0.05-5 µg/mL and a concentration of hydrochlorothiazide of 0.02-1 µg/mL. The greenness of the developed method was evaluated by analytical eco-scale and the recently reported evaluation method, that is, green analytical procedure index, and it was found to be an excellent, sensitive, and green alternative to the reported methods. The developed method was validated according to the ICH guidelines and compared with the reference method. No significant difference was found in terms of accuracy.

Medienart:

E-Artikel

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Zur Gesamtaufnahme - volume:45

Enthalten in:

Journal of separation science - 45(2022), 4 vom: 03. Feb., Seite 824-831

Sprache:

Englisch

Beteiligte Personen:

Hemdan, Ahmed [VerfasserIn]
Al-Tannak, Naser F [VerfasserIn]
Mohamed, Ekram H [VerfasserIn]

Links:

Volltext

Themen:

0J48LPH2TH
50VV3VW0TI
Antihypertensive Agents
Atenolol
Fluorescence
Green
Hydrochlorothiazide
Journal Article
Response surface methodology

Anmerkungen:

Date Completed 07.04.2022

Date Revised 07.04.2022

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1002/jssc.202100711

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM334471087